Related Experiment Video
Updated: Jun 26, 2026
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Tau pathophysiology in neurodegeneration: a tangled issue
Tara L Spires-Jones1, William H Stoothoff, Alix de Calignon
1MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
Trends in Neurosciences
|January 24, 2009
Summary
Neurodegenerative tauopathies involve abnormal tau protein aggregates, leading to neuronal loss. This research proposes a non-apoptotic cell death pathway in tauopathy, distinct from programmed cell death.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Neurodegenerative tauopathies are characterized by hyperphosphorylated tau protein aggregates.
- These aggregates correlate with synapse and neuronal loss in the brain.
- Altered tau conformation leads to loss of function and increased aggregation.
Purpose of the Study:
- To discuss the pathophysiology of tau in neurodegenerative diseases.
- To explore emerging evidence linking tau changes to neuronal death.
- To propose a specific mechanism of cell death in tauopathy.
Main Methods:
- Literature review and synthesis of recent evidence on tau pathophysiology.
- Analysis of molecular mechanisms underlying tau aggregation and neuronal dysfunction.
- Conceptual framework development for non-apoptotic cell death in tauopathy.
Main Results:
- Tau protein aggregation is a central feature of tauopathies.
- Conformational changes in tau contribute to its toxicity and aggregation.
- Evidence suggests a non-apoptotic caspase-associated cell death pathway in tauopathy.
Conclusions:
- Tau pathophysiology is complex, involving conformational changes and aggregation.
- Neuronal death in tauopathy may occur through a non-apoptotic mechanism.
- Understanding this cell death pathway is crucial for therapeutic development.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...